OTCMKTS:WILYY - WILLIAM DEMANT/ADR Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $15.15 0.00 (0.00 %) (As of 03/18/2019 02:16 PM ET)Previous Close$15.15Today's Range$15.15 - $15.1552-Week Range$14.30 - $23.90VolumeN/AAverage Volume61 shsMarket Capitalization$7.43 billionP/E Ratio26.12Dividend YieldN/ABeta0.72 ProfileDiscussionAnalyst RatingsChartHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email William Demant Holding A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment designed to aid the people with hearing loss connect and communication primarily in Denmark, rest of Europe, North America, Oceania, Asia, and other countries. Its products include hearing devices and implants; diagnostic instruments; and personal communication systems, such as headsets and solutions for the professional call center and office market, as well as consumer headsets for the gaming and mobile segments. The company was founded in 1904 and is headquartered in Smørum, Denmark. Receive WILYY News and Ratings via Email Sign-up to receive the latest news and ratings for WILYY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry N/A Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:WILYY Previous SymbolNASDAQ:WILYY CUSIPN/A CIKN/A Webwww.demant.com Phone45-3917-7300Debt Debt-to-Equity Ratio0.23 Current Ratio0.74 Quick Ratio0.55Price-To-Earnings Trailing P/E Ratio26.12 Forward P/E Ratio21.34 P/E Growth1.78 Sales & Book Value Annual Sales$2.21 billion Price / Sales3.37 Cash Flow$0.6159 per share Price / Cash Flow24.60 Book Value$2.12 per share Price / Book7.15Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees13,280 Outstanding Shares490,440,000Market Cap$7.43 billion Next Earnings DateN/A OptionableNot Optionable WILLIAM DEMANT/ADR (OTCMKTS:WILYY) Frequently Asked Questions What is WILLIAM DEMANT/ADR's stock symbol? WILLIAM DEMANT/ADR trades on the OTCMKTS under the ticker symbol "WILYY." Has WILLIAM DEMANT/ADR been receiving favorable news coverage? News stories about WILYY stock have been trending somewhat positive on Monday, according to InfoTrie. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. WILLIAM DEMANT/ADR earned a daily sentiment score of 1.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. Who are some of WILLIAM DEMANT/ADR's key competitors? Some companies that are related to WILLIAM DEMANT/ADR include ESSILOR INTL S/S (ESLOY), Zimmer Biomet (ZBH), Centene (CNC), Eisai (ESALY), Fresenius Medical Care AG & Co. (FMS), TERUMO CORP/ADR (TRUMY), McKesson (MCK), LONZA GRP AG/ADR (LZAGY), Fresenius Medical Care AG & Co. KGaA (FME), COLOPLAST A/S/ADR (CLPBY), Canopy Growth (WEED), Align Technology (ALGN), Cerner (CERN), IDEXX Laboratories (IDXX) and Incyte (INCY). What other stocks do shareholders of WILLIAM DEMANT/ADR own? Based on aggregate information from My MarketBeat watchlists, some companies that other WILLIAM DEMANT/ADR investors own include Acacia Communications (ACIA), Tractor Supply (TSCO), Gentex (GNTX), Core Laboratories (CLB), Pacific Biosciences of California (PACB), Johnson & Johnson (JNJ), Spark Therapeutics (ONCE), IMI (IMI), Proto Labs (PRLB) and Tabula Rasa HealthCare (TRHC). Who are WILLIAM DEMANT/ADR's key executives? WILLIAM DEMANT/ADR's management team includes the folowing people: Mr. Søren Nielsen, Chief Exec. Officer, Pres, Member of Exec. Board and Pres of Oticon A/S (Age 48)Mr. René Schneider, Chief Financial Officer and Member of Exec. Board (Age 45)Mr. Søren Bergholt Andersson, VP of Investor Relations (Age 41)Ms. Trine Kromann-Mikkelsen, VP of Corp. Communication & RelationsMr. Jes Olsen, Pres of Oticon Medical How do I buy shares of WILLIAM DEMANT/ADR? Shares of WILYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is WILLIAM DEMANT/ADR's stock price today? One share of WILYY stock can currently be purchased for approximately $15.15. How big of a company is WILLIAM DEMANT/ADR? WILLIAM DEMANT/ADR has a market capitalization of $7.43 billion and generates $2.21 billion in revenue each year. The company earns $288.80 million in net income (profit) each year or $0.58 on an earnings per share basis. WILLIAM DEMANT/ADR employs 13,280 workers across the globe. What is WILLIAM DEMANT/ADR's official website? The official website for WILLIAM DEMANT/ADR is http://www.demant.com. How can I contact WILLIAM DEMANT/ADR? WILLIAM DEMANT/ADR's mailing address is Kongebakken 9, Smorum G7, 2765. The company can be reached via phone at 45-3917-7300 or via email at [email protected] MarketBeat Community Rating for WILLIAM DEMANT/ADR (OTCMKTS WILYY)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 134 (Vote Outperform)Underperform Votes: 199 (Vote Underperform)Total Votes: 333MarketBeat's community ratings are surveys of what our community members think about WILLIAM DEMANT/ADR and other stocks. Vote "Outperform" if you believe WILYY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WILYY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/18/2019 by MarketBeat.com StaffFeatured Article: Why is the LIBOR significant?